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Background: Severe calorie restriction (CR) is shown to improve or even reverse β-cell dysfunction in patients with
obesity and type 2 diabetes mellitus. However, whether mild to moderate CR can reverse β-cell dysfunction induced
by obesity and the underlying mechanism remain unclear. Autophagy plays an important role in maintaining mass,
architecture and function of β-cells. While the impact of CR on β-cell autophagy is unknown. This study aims to
investigate the effects of moderate CR on β-cell function and autophagy activity in diet-induced obese (DIO) mice.
Methods: DIO C57BL/6 mice were subjected to 3 weeks of switching to normal chow (HF→ NC group) or
normal chow with 40 % CR (HF→ NC CR group). Then hematoxylin-eosin and immunohistochemistry staining
were performed to observe β-cell morphology. β-cell function was evaluated by intraperitoneal glucose tolerance
test in vivo and static GSIS (glucose-stimulated insulin secretion) in isolated islets. β-cell autophagy activity was
determined by transmission electron microscope and western blot.
Results: In the HF→ NC CR group, CR normalized body weights, completely restored glucose tolerance, early-
phase and second-phase insulin secretion, insulin sensitivity, and islet size. CR also normalized insulin content and
glucose-stimulated insulin secretion in isolated islets in vitro. Furthermore, β-cell autophagy level was increased in
the HF→ NC CR group, but AMPK phosphorylation remained unchanged. Although HF→ NC mice achieved
moderate weight loss and normal glucose tolerance, their insulin secretion was not improved compared with
obese control mice, and additionally, β-cell autophagy was not activated in these mice.
Conclusions: Moderate (40 %) CR to achieve normal weight reversed β-cell dysfunction and insulin resistance,
and restored glucose homeostasis in DIO mice. Furthermore, the up-regulation of β-cell autophagy may play a
role in this process, independent of AMPK activation.
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The prevalence of obesity and associated health conse-
quences, including type 2 diabetes mellitus (T2DM), con-
tinues to increase [1, 2]. Obesity not only causes insulin
resistance, but also leads to pancreatic β-cell damage
which manifests as the impaired insulin secretion in re-
sponse to glucose and nonfuel stimuli rather than reduced
β-cell mass [3]. Diet control can effectively reduce body
weight and delay the progression of obesity to T2DM [4].* Correspondence: yszhou@ccmu.edu.cn
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standardized, and it is important to find an effective and
feasible dietary intervention strategy to improve or even
reverse obesity-induced β-cell dysfunction.
Calorie or dietary restriction (CR) can significantly im-
prove β-cell function in subjects with obesity and T2DM.
Clinical studies have demonstrated an improvement in in-
sulin secretion in morbidly obese patients with T2DM,
after 1 week of very low–calorie diet (VLCD) of 400 kcal/
day or 3 weeks of 500 kcal/day [5, 6]. Furthermore, an-
other study have indicated that insulin secretion rate and
first-phase insulin response are normalized after 8 weeks
of VLCD (600 kcal/day) in patients with T2DM [7]. Alldistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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be accepted by most patients. However, the effects of
mild-to-moderate CR on β-cell function in subjects
with obesity have not been well investigated, and re-
lated studies mainly focus on the improvement of insu-
lin resistance [8, 9]. Studies of CR in obese animal
models often use 30–40 % (moderate) CR with a focus
on insulin resistance, however, the effect of CR on β-
cells has not been studied extensively [10, 11]. There-
fore, whether mild-to-moderate CR can reverse β-cell
dysfunction induced by obesity has not yet been dem-
onstrated and the molecular mechanisms mediating
this beneficial effect remain unclear.Fig. 1 The body weight and energy intake of the five groups during the e
beginning at age 4 weeks, then they were divided into five groups: NC AL
treatments continued for another 3 weeks. a the body weight and (b) ene
were presented as means ± SE, n = 20. a indicates P < 0.05 versus NC AL gr
normal chow; HF, high-fat diet; AL, ad libitum; CR, calorie restrictionAutophagy as a cellular degradation-recycling system
for aggregated proteins and damaged organelles can be
induced under energy deprivation conditions such as
starvation [12, 13]. Autophagy plays an important role in
maintaining mass, architecture and function of β-cells
[14]. A study has shown an increased β-cell autophagy
in high-fat-fed mice, and inductive β-cell autophagy acts
as a compensatory mechanism in response to obesity
[13]. However, the impact of weight loss or CR on β-cell
autophagy remains unknown.
This study used diet-induced obese (DIO) mice sub-
jected to 3 weeks of switching to normal chow (HF→
NC) or normal chow with 40 % CR (HF→NC CR), andxperiment. Male C57BL/6 mice were fed either NC or HF for 8 weeks
, NC CR (40 % CR), HF AL, HF→ NC, HF→ NC CR (40 % CR), these
rgy intake were evaluated throughout the experimental period. Data
oup; b indicates P < 0.05 versus HF AL group. Abbreviations: NC,
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verse β-cell dysfunction induced by obesity. Furthermore,
we also sought to explore whether β-cell autophagy was
involved in this process.
Methods
Animals and diets
Four weeks old male C57BL/6 mice were purchased
from Vital River Laboratories (Beijing, CHN). They were
random fed high-fat diet (HF) (Research Diets D12492;
60 % KJ from fat, 20 % KJ from carbohydrate, and 20 %
KJ from protein, 21.9 KJ/g, n = 60) or normal chow (NC)
(Research Diets D12450J; 10 % KJ from fat, 70 % KJ from
carbohydrate, and 20 % KJ from protein, 16.1 KJ/g, n = 40)
for 8 weeks. Then they were randomly divided into the
following five groups (n = 20/group): NC AL (ad libitum),
NC CR, HF AL, HF→NC (HF switching to NC, ad
libitum), HF→NC CR. The food intakes of both CR
groups were 60 % of that of NC AL group (Fig. 1b). These
treatments continued for 3 weeks, because at that time
body weights of HF→NC CR mice reduced to the same
level as NC AL mice (Fig. 1a). Food intake and body
weight were measured on a daily and weekly basis, re-
spectively. All procedures were approved by the Animal
Ethics Commission of Capital Medical University.
Metabolic and plasma parameters
After overnight fasting and anesthetization, the body
length, body weight, and abdominal circumference were
measured, and then Lee index was calculated [15]. Be-
sides, epididymal fat, liver and pancreas were harvested
and weighted. Plasma triglycerides, total cholesterol, non-
esterified fatty acids (NEFA) and adiponectin concentra-
tions were determined by commercially available kits
(Wako for lipid profiles; Alpco for adiponectin).
Intraperitoneal glucose tolerance test (IPGTT)
After a 16 h fasting, 25 % glucose (2 g/kg) was adminis-
tered intraperitoneally. Tail blood samples were collected
at 0, 15, 30, 60, and 120 min, and blood glucose was
measured by a portable glucometer (ContourTMTS).
Plasma insulin level was measured by ELISA (Alpco).
Insulinogenic index was calculated to assess early-phase
insulin secretion according to the formula: [15 min insu-
lin (μU/mL)-fasting insulin] / [15 min glucose (mmol/
L)-fasting glucose] [16]. Area under the curve (AUC) for
glucose and AUC for insulin (representing second-phase
insulin secretion) were calculated using the trapezoid
method. Insulin resistance was estimated by homeostasis
model assessment of insulin resistance (HOMA-IR).
Histological analysis
The samples of pancreas were fixed in 10 % neutralized
formalin and then embedded in paraffin and cutted into5 μm sections. Standard hematoxylin and eosin (HE) stain-
ings were performed. The pancreas sections were subjected
to immunohistochemistry (IHC) staining with primary anti-
body against insulin (1:400, Santa Cruz). Images were cap-
tured with a microscope (ECLIPSE80i/90i).Transmission electron microscopy (TEM)
After fixation in 3 % glutaraldehyde, pancreas tail sam-
ples were postfixed with 1 % OsO4 and embedded in
Epon812. Ultrathin sections were mounted and stained
with uranyl acetate/lead citrate (JEM-1400).Islet isolation
Islets were isolated from overnight fasted mice by the col-
lagenase digestion technique and followed by overnight
culture for recovery [17]. To determine islet size, images
were taken using a DMI 4000B inverted microscope
(Leica) and analyzed by Image-Pro Plus 3.0 software.Glucose-stimulated insulin secretion and insulin content
measurements
Static glucose-stimulated insulin secretion (GSIS) experi-
ment was performed as described [17]. Briefly, islets
were starved in Krebs-Ringer bicarbonate-HEPES buffer
(KRBH) for 1 h. Then batches of 10 size-matched islets
were pipetted into 24-well plates and treated with 2 ml
of KRBH containing 2.8 mM or 16.7 mM glucose for
1 h. The supernatant was collected for assay of insulin
release. For determination of islet insulin contents, ali-
quots of five islets were lysed in acid-ethanol solution
[18]. Insulin was measured by ELISA as described above.Western blot analysis
Groups of 300 freshly isolated islets (n = 6) were pelleted
and resuspended in 40 μL of lysis buffer. Equal amounts
of protein (30 μg) were resolved by electrophoresis and
then transferred to PVDF membranes. The membranes
were probed overnight at 4 °C with primary antibodies
against LC3 (1:500), p62 (1:1000) (both MBL), beclin-1
(1:1000), pT172-AMPKα (1:500), and AMPKα (1:500)
(all Cell Signaling), and then incubated with Dylight-
labeled secondary antibodies (1:10000, KPL) for 1 h. Im-
ages were quantified by the Odyssey infrared imaging
system (LI-COR Biosciences).Statistical analysis
Measurement data was expressed as means ± SE. One-
way ANOVA with LSD or S-N-K post hoc testing were
employed for multiple comparisons. Categorical vari-
ables were presented as percentages and analyzed by
Chi-squared test. P < 0.05 was considered statistically
significant.
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Body weight, organs weight and plasma parameters
As shown in Fig. 1a, after 8 weeks of HF feeding, DIO
models were successfully established [19], with a 45.1 %
marked increase in body weight compared with control
mice, meanwhile, the energy intake was significantly in-
creased by 22.8 % (Fig. 1b). After 3 weeks of CR inter-
vention, HF→NC CR mice achieved normal weight.
Although the HF→NC group achieved a 26.1 % weight
reduction compared with HF AL mice, they remained
more obese than NC AL mice.
As shown in Table 1, HF AL mice showed dramatically
increased abdominal circumference and significantly in-
creased weights of epididymal fat, liver and pancreas,
along with hyperlipidemia and hypoadiponectinemia. In
the HF→NC CR group, these parameters were normal-
ized or even lower than those in the NC AL group. Al-
though adiposity and metabolic characteristics were
improved in the HF→NC group, the epididymal fat
weight, blood lipid profile, and plasma adiponectin level
still did not return to normal levels. Besides, NC CR
group showed the lowest body weight and metabolic
parameters, however, the pancreas weight, plasma total
cholesterol, NEFA and adiponectin levels were un-
affected by 3 weeks of CR.
Effects of CR on pancreatic islet morphology and β-cell
area
HE and IHC staining demonstrated hypertrophic islets
and increased β-cell area (positive staining area forTable 1 Metabolic characteristics of the five groups at the end of th
Parameter NC AL NC CR
Body weight (BW, g) 26.35 ± 0.38 21.12 ± 0.33 *
Abdominal circumference (cm) 7.4 ± 0.2 6.6 ± 0.1 *
Lee index 323.18 ± 2.89 313.09 ± 3.67 *
Epididymal fat weight (%BW) 1.41 ± 0.11 0.20 ± 0.06 *
Liver weight (mg) 1115.0 ± 20.0 828.0 ± 47.3 *
Pancreas weight (mg) 184.0 ± 20.0 186.3 ± 9.7
Fasting blood glucose (mmol/L) 4.9 ± 1.2 3.6 ± 1.8
Fasting plasma insulin (ng/mL) 0.18 ± 0.05 0.13 ± 0.08
AUCglc0–120 (mmol/L ×min) 880.1 ± 119.4 423.6 ± 109.1
AUCins0–120 (ng/mL ×min) 22.66 ± 1.92 18.96 ± 4.22
Insulinogenic index 0.56 ± 0.07 0.96 ± 0.21
HOMA-IR 0.87 ± 0.12 0.58 ± 0.17
Plasma triglycerides (mg/dl) 30.28 ± 2.16 19.63 ± 2.40 *
Plasma total cholesterol (mg/dl) 70.60 ± 3.59 58.97 ± 3.85
Plasma NEFA (mmol/L) 0.79 ± 0.06 0.63 ± 0.05
Plasma adiponectin (μg/ml) 18.94 ± 1.18 18.71 ± 3.17
Data are presented as mean ± SE, n = 8 ~ 16. * indicates P < 0.05 versus NC AL grou
Abbreviations: NC normal chow, HF high-fat diet, AL ad libitum, CR calorie restrictioninsulin) in the pancreas of HF AL mice (Fig. 2a and b),
which were improved in the HF→NC mice and nor-
malized in the HF→NC CR mice. Similar trends were
also observed in isolated islets ex vivo (Fig. 3a). Quanti-
tative analysis revealed that islet size was increased by
8.1 % in HF AL mice and reduced to normal size in
both the HF→NC and HF→NC CR groups (Fig. 3b).
Additionally, NC CR mice had the smallest islets.Effects of CR on glucose tolerance, insulin sensitivity,
insulin secretion and insulin content
As shown in Fig. 4a, b and Table 1, HF AL mice devel-
oped glucose intolerance and insulin resistance. Fasting
blood glucose, AUC for glucose, fasting plasma insulin,
and HOMA-IR in HF AL mice were increased by
60.7 %, 1.0-fold, 3.1-fold, and 5.9-fold, respectively. The
AUC for insulin (second-phase insulin secretion) was in-
creased by 53.8 %, whereas the insulinogenic index
(early-phase insulin secretion) tended to decrease,
though no statistically different from the NC AL group
(Table 1). After CR intervention, all these parameters
were normalized in the HF→NC CR group. HF→NC
mice showed normal glucose tolerance and higher insu-
lin levels, implying that insulin resistance remained
higher than in the NC AL group. Furthermore, they also
showed unimproved early-phase insulin secretion com-
pared to the HF AL group. NC CR mice presented nor-
mal plasma insulin levels and unchanged early-phase
insulin secretion, but blood glucose levels at 15, 30 ande study
HF AL HF→ NC HF→ NC CR
41.23 ± 1.16 * 30.49 ± 0.70 *,** 26.83 ± 0.67 **
9.0 ± 0.2 * 7.6 ± 0.1 ** 6.9 ± 0.1 *,**
332.83 ± 2.43 * 321.82 ± 2.75 ** 320.38 ± 3.00 **
4.94 ± 0.19 * 2.37 ± 0.25 *,** 1.26 ± 0.32 **
1263.1 ± 74.1 * 1052.2 ± 45.4 ** 882.0 ± 35.2 *,**
295.0 ± 14.9 * 211.1 ± 13.8 ** 194.4 ± 11.1 **
7.9 ± 2.2 * 5.8 ± 0.7 ** 5.7 ± 1.5 **
0.74 ± 0.14 * 0.29 ± 0.07 *,** 0.20 ± 0.07 **
* 1768.3 ± 166.8 * 1077.2 ± 136.5 ** 569.9 ± 100.0 **
34.86 ± 2.34 * 25.74 ± 3.86 ** 24.54 ± 2.70 **
0.32 ± 0.22 0.59 ± 0.09 0.93 ± 0.22 **
5.97 ± 1.00 * 1.54 ± 0.11 ** 1.17 ± 0.25 **
43.86 ± 3.88 * 38.13 ± 2.97 * 16.47 ± 1.19 *,**
152.17 ± 6.65 * 83.72 ± 4.60 *,** 65.34 ± 3.30 **
1.30 ± 0.06 * 1.03 ± 0.10 *,** 0.67 ± 0.06 **
11.82 ± 1.64 * 12.80 ± 1.85 * 17.71 ± 1.49 **
p; ** indicates P < 0.05 versus HF AL group
, NEFA non-esterified fatty acid
Fig. 2 Effects of CR on pancreatic islet morphology and β-cell area. a representative images of H&E staining of pancreatic sections. Scale bars:
20 μm. b pancreatic sections were immunostained for insulin and the positive staining area represented β-cell area. Scale bars: 20 μm
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AL group.
To eliminate the interference of insulin resistance
in vivo, we evaluated GSIS in isolated islets ex vivo. As
shown in Fig. 5a, HF AL islets had defective insulin se-
cretion, with a 30.6 % increase in basal insulin secretion
and a 52.1 % reduction of insulin secretion in response
to 16.7 mM glucose compared with NC AL group. For
HF→NC CR islets, both basal and high glucose-
stimulated insulin secretion were completely restored.
Although basal insulin secretion returned to normal in
HF→NC islets, high glucose-stimulated insulin secre-
tion was still unimproved relative to the HF AL group.
The stimulation index (SI) was calculated by dividing
high glucose-stimulated insulin secretion by basal insulin
secretion. HF AL islets displayed the lowest SI, which
was not enhanced in HF→NC islets but fully recovered
in HF→NC CR islets (Fig. 5b). Insulin content in iso-
lated islets increased by 28.3 % in the HF AL group and
reduced to normal levels in both the HF→NC andFig. 3 Effects of CR on the size of isolated islets. a representative images of is
mean size of islets determined by measuring of 250 ~ 350 islets (from 5 mice)
versus HF AL groupHF→NC CR groups (Fig. 5c), in accordance with the
results of the IHC analysis. NC CR islets showed the
lowest insulin content and basal insulin secretion, how-
ever, high glucose-stimulated insulin secretion was com-
parable with NC AL islets.
Effects of CR on autophagy and expression of
phosphorylated adenosine monophosphate-activated
protein kinase (AMPK) in islets
Next, we detected the protein expressions of beclin-1,
LC3II/LC3I (two specific markers for induction and for-
mation of autophagosomes) and p62 (a marker being de-
graded by autophagy) in freshly isolated islets. Our
findings showed significantly increased LC3II/LC3I ratio
and beclin-1 level with remarkably decreased p62 accu-
mulation in the NC CR, HF AL and HF→NC CR islets,
indicating β-cell autophagy was activated in these three
groups, but there were no differences in autophagy levels
among these three groups. Autophagy levels in HF→
NC islets were not different from those of the NC ALolated islets after overnight culture for recovery. Scale bars: 500 μm. b the
per group. a indicates P < 0.05 versus NC AL group; b indicates P < 0.05
Fig. 4 Effects of CR on glucose tolerance, early-phase and second-phase insulin secretion and insulin sensitivity. Blood glucose (a) and plasma
insulin (b) were measured at times 0, 15, 30, 60, and 120 min in response to a glucose challenge (i.p. 2 g/kg) in 16-h fasted conscious mice. Data
were presented as means ± SE, n = 6–8 mice/group. a indicates P < 0.05 versus NC AL group; b indicates P < 0.05 versus HF AL group. Abbreviations:
i.p., intraperitoneally; AUC, area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance
Fig. 5 Effects of CR on glucose-stimulated insulin secretion and insulin content in isolated islets. a glucose-stimulated insulin secretion was measured
in isolated islets (10 islets per concentration in triplicates) at 2.8 and 16.7 mM glucose. b the stimulation index calculated by dividing
insulin secretion in response to 16.7 mM glucose by that in response to 2.8 mM glucose. c insulin content of isolated islets was measured in
batches of 5 islets in triplicates. Data were presented as means ± SE, n = 5 mice/group. a indicates P < 0.05 versus NC AL group; b indicates P < 0.05
versus HF AL group
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by TEM, which also showed an increased presence of
autophagosomes in β-cells from the NC CR, HF AL and
HF→NC CR groups (Fig. 6)
Because both CR groups showed activated β-cell au-
tophagy, and autophagy activity was closely related with
the energy metabolism level, we further examined the
level of AMPK phosphorylation. The results showed that
AMPKα phosphorylation was up-regulated in NC CR is-
lets only, however, no significant differences were found
among the other four groups (Fig. 7e and f).
Discussion
In our study, chronic HF feeding was used to induce obes-
ity in male C57BL/6 mice, which were then subjected to
3 weeks of switching to NC or 40 % CR to induce weight
loss. Our findings demonstrated that moderate (40 %) CR
to achieve normal weight could reverse β-cell dysfunction
and insulin resistance, and restore glucose tolerance in
DIO mice. The activation of β-cell autophagy might par-
ticipate in this process.
After 12 weeks of HF feeding, HF AL mice became re-
markably obese, and showed glucose intolerance and in-
sulin resistance, accompanying by hypertrophic islets
and increased β-cell area. Moreover, their early-phaseFig. 6 Transmission electron microscopic evaluation of
autophagosomes in β-cells of mice. The pancreas tail tissues were
collected for TEM analysis. Granular cytoplasm or degenerated
organelles surrounded by double membrane representing
autophagosomes (white arrows) were seen in β-cells of NC CR, HF AL
and HF→NC CR mice. Images were representative of all the
experiments (n = 3), scale bars: 0.5 μm. Abbreviations: TEM, transmission
electron microscopy; N, nucleus; M, mitochondria; IG, insulin granulesinsulin secretion tended to decrease and second-phase
insulin secretion elevated significantly in vivo. This
phenomenon is also commonly observed in patients
with IGT (impaired glucose tolerance) or early-stage
T2DM. Ex vivo isolated islets had increased insulin con-
tent and defective insulin secretion that manifested as
enhanced basal insulin secretion and reduced high
glucose-stimulated insulin secretion, suggesting β-cell
dysfunction in HF mice was not due to insufficient insu-
lin storage but to a defective secretion. These findings
were consistent with previous studies [3, 20] that noted
this secretory dysfunction was possibly caused by the re-
duced ATP/Ca2+ signaling. In vitro experiments elimi-
nated the interference of confounding factors in vivo,
such as insulin resistance, therefore it would be more ac-
curate to reflect β-cell function. Furthermore, we ob-
served activated β-cell autophagy in HF AL mice, this
was in line with a previous study [13]. Several reasons
could contribute to this phenomenon. Insulin resistance,
free fatty acids (FFA), and misfolded proteins caused by
endoplasmic reticulum stress are increased in obesity,
and all of these factors can activate β-cell autophagy
[21]. Obesity-induced activation of β-cell autophagy is
considered as a compensatory response, providing cells
with a safety mechanism to eliminate damaged mito-
chondria and/or other cellular components and to avoid
cell apoptosis under insulin-resistant states and high
FFA concentrations [13]. However, although enhanced
β-cell autophagy played a protective role in HF AL mice,
it was not strong enough to compensate for β-cell dam-
age, therefore HF AL mice still had β-cell dysfunction.
It is reported that treating obesity by CR using a low
fat diet attenuates the rebound weight gain compared
with CR using an HF diet [22]. This was the basis of
why we subjected DIO mice to CR with normal chow ra-
ther than CR with an HF diet. After 3 weeks of CR,
HF→NC CR mice achieved normal weight, and fully re-
covered glucose tolerance, insulin sensitivity, insulin se-
cretion and insulin content. Besides, increased organs
weight, hyperlipemia, hypoadiponectinemia, and hyper-
trophic islets all returned to normal. Similarly, Lim et al.
provided 11 newly diagnosed T2DM patients with VLCD
of 600 kcal/day, and found that fasting blood glucose
and hepatic insulin sensitivity fell to normal after 1 week
of CR and β-cell function (insulin secretion rate and
first-phase insulin response) increased towards normal
over the 8 weeks of CR [7]. These results support our
finding. Although the degree and duration of CR were
different in these two studies, both studies confirmed β-
cell dysfunction could be reversed by CR in obesity and
the early stage of T2DM. However, it is very difficult to
maintain this severe CR strategy. Another animal study
[10] demonstrated that body weight and glucose toler-
ance were normalized after 3 weeks of 40 % CR in ob/ob
Fig. 7 Effects of CR on the expression of autophagy markers and phosphorylated AMPK in islets. a LC3, beclin-1 and p62 protein levels in freshly
isolated islets were determined by western blot, β-actin was used as an internal standard and representative blots were shown. b the ratio of
LC3-II to LC3-I(n = 6). c and d the protein expressions of beclin-1 and p62 relative to β-actin (n = 6). e Representative blots of phosphorylated and
total AMPKα protein expression in freshly isolated islets. f the ratio of pT172-AMPKα to total AMPKα (n = 6). Data were presented as means ± SE, a
indicates P < 0.05 versus NC AL group; b indicates P < 0.05 versus HF AL group
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ing insulin sensitivity was not restored. However, β-cell
functions such as insulin synthesis and secretion were
not explored in this study. Discrepancies in the restor-
ation of insulin sensitivity between this previous study
and our findings might be due to the difference in obese
animal models used. Moreover, we further investigated
the role of autophagy in this process and found that β-
cell autophagy was activated in HF→NC CR mice. To
our knowledge no study has yet reported the effect of
CR on β-cell autophagy in obese mice, and there are
only few studies that have reported autophagy is up-
regulated in the heart and liver during CR in DIO mice
or diabetic rats [23, 24]. Owing to the fact that autoph-
agy can be activated under nutrient-poor conditions to
maintain energy homeostasis [12, 13], we suppose that
the sudden negative energy balance may contribute to
the activation of β-cell autophagy in HF→NC CR mice.
Considering the beneficial effect of autophagy on β-cells
[13, 25], the activation of β-cell autophagy mightcontribute to the restoration of β-cell functions in HF→
NC CR mice.
Switching from HF to NC without CR for 3 weeks nor-
malized glucose tolerance, and reduced (but not normal-
ized) body weight. It also showed unimproved early-phase
insulin secretion in vivo and GSIS in vitro. Similarly,
Agardh CD et al. demonstrated that switching from high-
fat diet to low-fat diet for 4 weeks normalized glucose tol-
erance and reduced body weight in C57BL/6 J mice [26].
However, in contrast to our results, they showed improved
early-phase insulin secretion in vivo. This might be due to
that their treatments lasted for longer time. Additionally,
many studies have indicated blood glucose levels return to
normal earlier than body weight or insulin secretion [7, 9].
As HF→NC mice showed, although they achieved
normoglycemia, defective insulin secretion still existed.
Additionally, β-cell autophagy was not activated in HF→
NC CR mice, which might be related with the unimproved
insulin secretion of these mice. These findings suggest that
besides normoglycemia, restoring β-cell function should
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intervention studies for obesity and T2DM.
In addition to applying CR on obese mice, we also evalu-
ated the effects of CR on normal mice, and found decreased
islet size and insulin content with unchanged GSIS, sug-
gesting insulin storage but not insulin secretion was re-
duced. This was supported by a study that demonstrated
CR potentiated amino acid-stimulated insulin secretion
(AASIS) instead of GSIS [27]. Similar to that reported by
Fok et al. [28], we also observed reduced blood glucose
levels during IPGTT, although plasma insulin levels were
normal, which might be explained by elevated insulin sensi-
tivity in NC CR mice. Similar to the induced β-cell autoph-
agy in 24-h fasted mice [12], we found β-cell autophagy
was up-regulated in NC CR mice, and this might be due to
acute energy depletion that was further confirmed by the
presence of activated AMPK. However, both induction and
inhibition of autophagy have been reported in starved INS-
1 cells (a rat insulinoma-derived β-cell line), the variation of
timing when depletion occurs might explain this inconsist-
ency [13, 29]. As reported by previous studies, the up-
regulation of β-cell autophagy can increase insulin secretion
[13, 14, 29]. However, in our study, the insulin secretion of
NC CR mice was comparable with that of NC AL group.
The following reasons might explain this phenomenon. On
the one hand, the activated β-cell autophagy in these mice
could increase insulin secretion, but on the other hand, the
fasting blood glucose levels of NC CR mice tended to
decrease owing to their inadequate energy intake, and the
decline of blood glucose levels would initiate the self-
regulation mechanism of the body to reduce insulin secre-
tion. So in general, the fasting plasma insulin levels of NC
CR mice were kept in normal. In a word, short-term CR on
normal mice had no significant effect on β-cell functions.
CR as an energy deficiency condition is closely related
to increased intracellular AMP (adenosine monopho-
sphate) level, which can lead to AMPK activation. And
AMPK activation can directly induce autophagy [30].
We found AMPK was activated only in NC CR islets.
However, the lack of AMPK activation in HF AL and
HF→NC CR mice was probably due to the energy chal-
lenge not being severe enough to cause changes in AMP,
and it implied the activation of β-cell autophagy in these
mice was not through the AMPK pathway. It is reported
that autophagy is a complex process regulated by mul-
tiple pathways including AMPK, mTOR, SIRT1, Bcl-2
and p53 [31, 32], therefore other pathways might be re-
sponsible for the activation of β-cell autophagy in HF
AL and HF→NC CR mice.
Conclusions
In conclusion, our study demonstrates for the first time
that moderate (40 %) CR to achieve normal weight can
reverse β-cell dysfunction and insulin resistance, andrestore glucose homeostasis in DIO mice. Our study
provides an encouraging sign that β-cell dysfunction is
completely reversible in obesity and the early stage of
T2DM. Furthermore, we propose that the activation of
β-cell autophagy may play a role in this process, inde-
pendent of AMPK activation. However, this hypothesis
still needs to be confirmed, for example by using β cell-
specific autophagy-deficient mice, and the responsible
signaling pathways still require clarification.
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